Saad, Dr Zia

MBBS, MRCSEd, MSc (nuclear medicine)Saad, Dr Zia (nuclear medicine) photo

Specialty

Nuclear medicine

Sub-specialty

Hybrid molecular imaging & radionuclide therapeutics

Training and education

  • MBBS (medical degree) - Baqai Medical College, University of Karachi, November 1998

  • CCBST (certificate of completion of basic surgical training) - The Surgical Royal Colleges of Great Britain and Ireland, January 2006

  • Membership of the Royal College of Surgeons of Edinburgh - February 2006

  • MSc (master of science) - King’s College London, August 2013

  • CCT (certificate of completion of training - specialist in nuclear medicine) - General Medical Council, November 2013

Experience

Dr Saad is a consultant in nuclear medicine who joined the Trust in 2016. Before coming to UHS, he was a consultant at University College London Hospital and Addenbrooke’s Hospital in Cambridge.

Dr Saad works within all aspects of nuclear medicine. He provides diagnostic and therapeutic services for patients in Hampshire and the neighbouring regions using radionuclide imaging, which uses a small dose of a radioactive chemical to produce scans of internal parts of the body. He carries out consultation clinics and supervises other clinicians’ work in nuclear medicine. He also administers radioactive medicinal probes for use in:

  • the treatment of thyroid disease

  • the treatment of myeloproliferative disorders (conditions that cause blood cells to grow abnormally in the bone marrow)

  • palliative treatment for bone pain caused by cancer

  • the treatment of pain caused by joint diseases like arthritis

  • selective internal radiation therapy for liver tumours and metastatic cancer

  • the treatment of neuroendocrine tumours in both children and adults.

Dr Saad has a particular interest in hybrid diagnostic molecular imaging, a technique that shows information from two different types of scan in the same image. This is used in the diagnosis of cancer as well as in the assessment of bones and joints, and to see how the heart and brain are functioning.

Key achievements

  • Introduced patient focused, streamlined radionuclide therapeutic/diagnostic clinical pathways at Addenbrooke’s Hospital, Cambridge.

  • Introduced and implemented SPECT/CT scans as routine modality in sentinel lymph node studies for uro-gynaecological cancer patients (penile, vulva and cervix) at the Institute of Nuclear Medicine - University College London.

Awards and prizes

  • Winner of best poster award at the British Association of Urological Surgeons' annual meeting, 2014

  • Multi-modality imaging award at the British Nuclear Medicine Society's annual conference, 2013

  • Completed masters in nuclear medicine: science and practice, with merit awards for thesis and practical applications of nuclear medicine

Research

Dr Saad is active in research. He's a peer reviewer and invited editor for various national and international scientific/imaging journals. His publications include:

  • Investigating the role of SPECT/CT in dynamic sentinel lymph node biopsy for penile cancers (EJNMMI 2017)

  • The effect of peptide receptor radionuclide therapy (PRRT) on symptoms and tumour burden in patients with metastatic neuroendocrine tumour (NET) (Endoabs 2016)

  • Use of 11C-methionine PET to localise parathyroid adenoma/hyperplasia: a single centre experience. (Endoabs 2015)

  • Sentinel lymph node: established and new areas of use (Clinical and Translational Imaging 2015)

  • Multi-functional imaging signature for v-ki-ras2 kirsten rat sarcoma viral oncogene homolog (kras) mutations in colorectal cancer. (JNM 2014)

  • Painful knee prosthesis: can we help with bone SPECT/CT? (NMC 2013)

  • Integrated PET/MRI; The new tool in multimodality imaging. (RADMAG 2013)

  • Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? (EJNMMI 2013)

Contact

You can contact Dr Saad via his secretary Michelle Bright - call 023 8120 6200/4321 or send an email.